About Fondaparinux Sodium
            
            Class: | Anticoagulant (Factor Xa inhibitor)  
Use: | Prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) in patients undergoing surgery; treatment of DVT and PE; prevention of thrombus formation in patients with unstable angina or non-ST elevation myocardial infarction (NSTEMI)  
Adult dose: | 2.5 mg subcutaneously once daily for DVT/PE prophylaxis; 5-10 mg subcutaneously once daily for treatment of DVT/PE, depending on the clinical scenario  
Pediatric dose: | Safety and effic
         
        
            
                
                
                    
                        Drug Class
                    
                    Anticoagulant (Factor Xa inhibitor)
                 
                
                
                    
                        Uses & Indications
                    
                    Prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) in patients undergoing surgery; treatment of DVT and PE; prevention of thrombus formation in patients with unstable angina or non-ST elevation myocardial infarction (NSTEMI)
                 
                
                
                    
                        Storage Requirements
                    
                    Store at 20°C to 25°C (68°F to 77°F); protect from light; do not freeze
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Glaxo Wellcome Production, FRANCE
                    
                    
                    Package Size
                    0.8ml Pre-filled Syringe x 10
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 927.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        2.5 mg subcutaneously once daily for DVT/PE prophylaxis; 5-10 mg subcutaneously once daily for treatment of DVT/PE, depending on the clinical scenario
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established; use is not recommended in pediatric patients
                    
                 
                
                
                    
                        Side Effects
                    
                    Bleeding, injection site reactions, anemia, thrombocytopenia, nausea
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Active major bleeding, severe renal impairment (creatinine clearance < 30 mL/min), hypersensitivity to fondaparinux or any component of the formulation
         
        
        
            
                Important Warnings
            
            Increased risk of bleeding; monitor for signs of bleeding; use caution in patients with renal impairment; not recommended for patients with a history of heparin-induced thrombocytopenia (HIT)
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.